 | Steven C. Gilman Sells 4,567 Shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA) Stock
americanbankingnews.com - June 9 at 5:48 PM |
 | Reflecting on Akebia Therapeutics' (NASDAQ:AKBA) Share Price Returns Over The Last Year
finance.yahoo.com - June 8 at 7:48 AM |
| Akebia Therapeutics, Inc. (NASDAQ:AKBA) Given Consensus Rating of "Buy" by Analysts
americanbankingnews.com - June 4 at 3:30 AM |
 | FDA accepts Akebia's vadadustat NDA for review
seekingalpha.com - June 4 at 12:23 AM |
| Akebia Therapeutics Announces Presentations at ERA-EDTA Virtual Congress 2021
finance.yahoo.com - June 3 at 9:22 AM |
| Akebia Therapeutics (NASDAQ:AKBA) Shares Gap Down to $3.41
americanbankingnews.com - June 2 at 10:55 AM |
| Akebia Therapeutics (NASDAQ:AKBA) Shares Gap Up to $3.51
americanbankingnews.com - June 1 at 11:14 AM |
| Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis
finance.yahoo.com - June 1 at 9:06 AM |
| Comparing Akebia Therapeutics (NASDAQ:AKBA) & Zealand Pharma A/S (NASDAQ:ZEAL)
americanbankingnews.com - May 31 at 5:02 AM |
 | Akebia Therapeutics, Inc.'s (NASDAQ:AKBA) CEO Might Not Expect Shareholders To Be So Generous This Year
nasdaq.com - May 27 at 2:44 AM |
|
 | Satter Management Co., L.p. Buys Aileron Therapeutics Inc
uk.finance.yahoo.com - May 20 at 8:50 AM |
| Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 12 at 10:30 AM |
 | Recap: Akebia Therapeutics Q1 Earnings
benzinga.com - May 10 at 9:07 AM |
| Akebia Reports First Quarter 2021 Financial Results and Highlights Recent Company Milestones
finance.yahoo.com - May 10 at 9:07 AM |
 | The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx
markets.businessinsider.com - April 29 at 8:39 AM |
| New England Journal of Medicine Publishes Results of Global Phase 3 Clinical Program of Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease
finance.yahoo.com - April 28 at 7:45 PM |
| Akebia Therapeutics to Report First Quarter 2021 Financial Results and Discuss Recent Business Highlights
finance.yahoo.com - April 28 at 9:44 AM |
| SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Akebia Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors
finance.yahoo.com - April 26 at 9:09 AM |
| What Type Of Shareholders Own The Most Number of Akebia Therapeutics, Inc. (NASDAQ:AKBA) Shares?
finance.yahoo.com - April 24 at 9:20 AM |
| Akebia Therapeutics to Present at 20th Annual Needham Virtual Healthcare Conference
finance.yahoo.com - April 12 at 8:49 AM |
| Akebia (AKBA) Files NDA for Vadadustat for Anemia Due to CKD
finance.yahoo.com - March 31 at 2:14 PM |
| Akebia Submits New Drug Application (NDA) to the FDA for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis
finance.yahoo.com - March 30 at 7:51 AM |
| AKBA Apr 2021 3.500 call
in.finance.yahoo.com - March 25 at 10:16 AM |
| Akebia Therapeutics Announces Poster Presentations and Educational Symposium at National Kidney Foundation 2021 Virtual Spring Clinical Meetings
finance.yahoo.com - March 25 at 10:16 AM |
| AKBA May 2021 2.500 call
in.finance.yahoo.com - March 25 at 12:47 AM |
| Akebia Therapeutics Announces Approval for Additional Indication of Riona® (ferric citrate hydrate) for the Treatment of Iron Deficiency Anemia in Adult Patients in Japan
finance.yahoo.com - March 24 at 9:46 AM |
|
| Akebia Therapeutics Celebrates World Kidney Day and National Kidney Month
finance.yahoo.com - March 11 at 8:52 AM |
| Looking Into Akebia Therapeutics's Return On Capital Employed
finance.yahoo.com - March 2 at 2:46 PM |
| Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 6:15 PM |
| Why Akebia Therapeutics Stock Is Plunging Today
finance.yahoo.com - February 25 at 3:43 PM |
| Akebia Reports Fourth Quarter and Full-Year 2020 Financial Results and Provides Business Updates
finance.yahoo.com - February 25 at 10:43 AM |
| Akebia Therapeutics Appoints LeAnne M. Zumwalt, Dialysis Industry Leader, to Board of Directors
finance.yahoo.com - February 18 at 1:49 PM |
| Akebia Therapeutics to Report Fourth Quarter and Full-Year 2020 Financial Results and Discuss Recent Business Highlights
finance.yahoo.com - February 8 at 8:35 AM |
| Return On Capital Employed Overview: Akebia Therapeutics
benzinga.com - January 29 at 1:01 PM |
| Akebia Therapeutics to Present at H.C. Wainwright Bioconnect 2021 Conference
finance.yahoo.com - January 6 at 8:11 AM |
| Akebia Therapeutics to Present at 39th Annual J.P. Morgan Healthcare Conference
finance.yahoo.com - January 4 at 10:48 AM |
| Is AKBA A Good Stock To Buy Now?
finance.yahoo.com - December 16 at 4:34 PM |
| Implied Volatility Surging for Akebia Therapeutics (AKBA) Stock Options
finance.yahoo.com - December 16 at 11:34 AM |
| AkebiaShares Program: Current Approaches for Managing Hyperphosphatemia and Caring for Patients via Telehealth
finance.yahoo.com - December 9 at 9:02 AM |
| The Play On Akebia Now
seekingalpha.com - November 29 at 8:14 AM |
| Akebia Therapeutics to Participate in Piper Sandler 32nd Annual Virtual Healthcare Conference
finance.yahoo.com - November 24 at 12:03 PM |
| News for Akebia Therapeutics Inc
markets.businessinsider.com - November 19 at 11:38 AM |
| Akebia Therapeutics Ranked 10th Fastest-Growing Company in North America on Deloitte's 2020 Technology Fast 500™
finance.yahoo.com - November 18 at 12:59 PM |
| Akebia Announces Manuscript Highlighting Global Phase 3 INNO2VATE Program Rationale, Study Design and Baseline Characteristics Published in Peer-Reviewed Medical Journal
finance.yahoo.com - November 16 at 8:59 AM |
| Is the Options Market Predicting a Spike in Akebia (AKBA) Stock?
finance.yahoo.com - November 12 at 11:45 AM |
| Some Akebia Therapeutics, Inc. (NASDAQ:AKBA) Analysts Just Made A Major Cut To Next Year's Estimates
nasdaq.com - November 10 at 10:27 AM |
| Akebia Therapeutics, Inc. (NASDAQ:AKBA) Analysts Are Reducing Their Forecasts For Next Year
finance.yahoo.com - November 10 at 10:27 AM |
| Akebia Therapeutics, Inc. (NASDAQ:AKBA) Analysts Are Cutting Their Estimates: Here's What You Need To Know
nasdaq.com - November 7 at 8:14 AM |
| Akebia Therapeutics, Inc. (NASDAQ:AKBA) Just Reported And Analysts Have Been Cutting Their Estimates
finance.yahoo.com - November 7 at 8:14 AM |
| Akebia Therapeutics, Inc. (AKBA) CEO John Butler on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 6 at 2:26 PM |
